IMUX Archived Articles
Immunic, Inc. (IMUX): Transforming the Multiple Sclerosis Treatment Landscape with a Groundbreaking Candidate
Published on March 12, 2025
Immunic, Inc. (IMUX): A Differentiated Approach to Tackling Chronic Inflammatory and Autoimmune Diseases
Published on November 17, 2024
Immunic, Inc. (NASDAQ:IMUX): A Promising Biotech Poised for Transformative Milestones
Published on September 24, 2024